GenoMed™ Adds IT Experts to Business Development Advisory Board
Contact: David Moskowitz MD FACP GenoMed, Inc. dwmoskowitz@genomed.com tel. 314-983-9933
ST. LOUIS--(August 24, 2005)--GenoMed Inc. ("the Company" or "GenoMed") (National Quotation Bureau's Pink Sheets symbol GMED) today announced the addition of IT experts Jack Gruninger and Chris Todd to its Business Development Advisory Board.
Jack Gruninger has over 15 years of experience in leading advanced Information Technology projects in the commercial and government sectors. He is currently Vice President – Technology for L-3 Communications Titan Corporation, founder of TapHere! Technology LLC, member of the Technology Advisory Board for the International Disease Management Association, and previously served as CTO for Brainbench.com.
Mr. Gruninger has provided technical presentations for many industry-leading technology conferences/seminars including the International Sybase Users Group, Professional Association for SQL Server, US Armed Forces Decision AIDS Conference, Armed Forces Communications & Electronics Association, and the Global Command & Control System Functional Working Group.
Chris Todd currently serves as Senior Software Engineer at L-3 Communications Titan Corporation, Vice President – Multimedia for TapHere! Technology LLC, and is a member of the Technology Advisory Board for the International Disease Management Association.
Mr. Todd has been a pioneer in commercial web technology and has extensive experience with leading-edge software/hardware design, database development, object-oriented programming, Internet / networking operations, optics, and multimedia. He has designed and developed over 30 enterprise-class, multi-tier software applications, many of which are deployed for operations and collaboration among leading health care organizations.
Said Dr. David Moskowitz, GenoMed's Chairman and CEO, "Our business relies entirely on the World Wide Web. Jack Gruninger and Chris Todd are experts in designing websites, adding multimedia content—video and audio--to websites, and making websites easy to find by search engines. To increase our revenue stream, we need a website that's easy for America's 80 million patients with diabetes and high blood pressure, and 5 million patients with emphysema, to find—not to mention the hundreds of millions of patients with these diseases worldwide."
About GenoMed™
GenoMed, Inc. is a Next Generation DM™ company whose mission is to improve patient outcomes by identifying the molecular pathways that cause disease. The company is currently marketing its protocols for preventing kidney failure due to diabetes and high blood pressure, and delaying the progression of emphysema. The company is also conducting a free clinical trial for West Nile virus; to enroll, simply click on the West Nile virus link at www.genomed.com
. |
